NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- UTime Limited (“UTime” or the “Company”) (Nasdaq: WTO), a mobile device manufacturing company committed to providing cost effective products and solutions to consumers globally and helping low-income individuals from established and emerging markets today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), at a ratio of 1-for-10, to be effective on or around the open of trading on March 31, 2025. Our Ordinary Shares will begin trading on a reverse share split-adjusted basis at the opening …

Orange 142 Partners with Tourism Economics to Deliver Advanced Attribution and Economic Impact Data for Destination Marketing Organizations — Neutral
DRCT PRNewsWire — March 26, 2025The partnership provides DMOs with tools to measure the real economic impact of digital marketing investments AUSTIN, Texas , March 26, 2025 /PRNewswire/ -- Orange 142 , a division of Direct Digital Holdings (NASDAQ: DRCT) and a leader in digital marketing solutions for destination marketing organizations, today announced a strategic partnership with Tourism Economics, an Oxford Economics company and global leader in tourism industry analysis. This collaboration brings destination marketing organizations' (DMOs) sophisticated attribution capabilities and economic impact dashboards, allowing them to directly connect their paid marketing efforts to visitor metrics and economic outcomes.

Amber International to Ring Nasdaq Closing Bell on March 28, 2025, Celebrating Successful Nasdaq Listing and Strategic Growth Momentum — Neutral
AMBR PRNewsWire — March 26, 2025SINGAPORE , March 26, 2025 /PRNewswire/ -- Amber International Holding Limited (Nasdaq: AMBR) ("Amber International," "we," "us," "Company," or "AMBR"), a leading provider of institutional crypto financial services & solutions and operating under the brand name "Amber Premium," today announced it will celebrate its recent Nasdaq listing and accelerating growth by ringing the Nasdaq Closing Bell on Friday, March 28, 2025 . The ceremony underscores Amber International's successful transition to a publicly listed company on March 13, 2025, when it began trading under the ticker symbol "AMBR.

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference — Neutral
NSPR GlobeNewsWire — March 26, 2025MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, at 8:00AM Eastern Time / 5:00AM Pacific Time. A live audio webcast and replay of the presentation may be accessed for 90 days on the “News & Events” section of the company's website at: https://www.inspiremd.com/en/events/ About InspireMD, Inc. InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry …

Broadcom Simplifies and Accelerates Private Cloud Lateral Security with VMware vDefend Innovations — Neutral
AVGO GlobeNewsWire — March 26, 2025PALO ALTO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Broadcom Inc. (NASDAQ: AVGO) today introduced new updates to VMware vDefend that enable organizations to up-level security planning and assessment, simplify lifecycle management and operations, and seamlessly scale security across application environments.

ABBOTT PARK, Ill., March 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2025 financial results on Wednesday, April 16, before the market opens.

Old Navy Partners with RADAR to Elevate the Customer Experience with Plans for Phased Roll Out of its AI-Powered RFID Technology — Neutral
GAP PRNewsWire — March 26, 2025New Technology Enables Store Associates to Track and Locate Inventory with a High Level of Accuracy to Drive a Seamless and Intelligent Shopping Experience SAN FRANCISCO , March 26, 2025 /PRNewswire/ -- RADAR , the technology platform that combines RFID, AI and computer vision technology to track and locate in-store inventory with a high level of accuracy in real-time, today announced a partnership with Old Navy, the largest brand in Gap Inc.'s (NYSE: GAP) house of iconic American brands. Old Navy's multi-year plans include a phased roll out of RADAR's AI-powered RFID technology across its nationwide store fleet to help …

Completion of New Fuel System Design Meets a Key Product and Engineering Q1 Milestone ENGLEWOOD, Colo. , March 26, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ: XTIA), a pioneer in VTOL and powered-lift aircraft solutions, today announced the successful update of its fuel system design, achieving a key 2025 first quarter product and engineering milestone announced in a prior press release.

RTX's Raytheon launches new Coyote variant from helicopter — Neutral
RTX PRNewsWire — March 26, 2025New variant designed for "launched-effects" programs builds off Coyote's battlefield success TUCSON, Ariz. , March 26, 2025 /PRNewswire/ -- Raytheon, an RTX (NYSE: RTX) business, fired a new version of the company's combat-proven Coyote® family of products from a helicopter during a recent test at Nine Mile Training Center, giving military forces a new capability to detect, identify, locate and defeat threats on the battlefield.

NEW RICE KRISPIES TREATS® BLISS RAISES THE 'BAR' ON SALTY-SWEET INDULGENCE — Neutral
K PRNewsWire — March 26, 2025The classic marshmallow treat just got even more decadent with two new fan-inspired flavors CHICAGO , March 26, 2025 /PRNewswire/ -- Nothing unlocks childlike joy quite like a Rice Krispies Treats ® bar and now the brand is turning up the indulgence with all-new Rice Krispies Treats Bliss bars. For the first time, the iconic marshmallow treat will feature multiple toppings – including a salty snack – to create a delicious multi-textural experience complete with a satisfying crunch.

Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca — Neutral
AZN PRNewsWire — March 26, 2025AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical settings and helping overcome barriers to molecular testing in NSCLC SEOUL, South Korea , March 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, will present a deep learning study on Epidermal Growth Factor Receptor (EGFR) mutation prediction in patients with non-small cell lung cancer (NSCLC) at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025, held from April 25 to 30 in Chicago, Illinois. The study, which highlights the development and validation of the Lunit …

UTF: Recent Investment Announcements Into The U.S. Will Provide Tailwinds For Infrastructure — Positive
UTF Seeking Alpha — March 26, 2025The Trump Administration's $3 trillion investment pledges are bullish for infrastructure, making Cohen & Steers Infrastructure Fund a strong investment for income and capital appreciation. UTF's diverse holdings in utilities, industrials, and energy sectors are poised to benefit from increased infrastructure spending, despite potential risks from leverage and sector concentration. UTF has a 21-year track record of uninterrupted distributions, and its 7.48% yield is attractive, especially as the Fed is expected to cut rates.

Ready, Set, Egg! Reese's and Cadbury Partner with Jasmine Roth to Kick Off a Fun New Easter Tradition — Neutral
HSY PRNewsWire — March 26, 2025Get inspired by the DIY guru's "egging" ideas and start your own chocolate-fueled ritual! HERSHEY, Pa.

IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep Disturbances — Neutral
IGC Accesswire — March 26, 2025- IGC-AD1 Could Offer Safer Alternative to Existing Sleep Medications for Alzheimer's - POTOMAC, MD / ACCESS Newswire / March 26, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") today announced additional positive interim results from its ongoing Phase 2 clinical trial on IGC-AD1, an investigational treatment for agitation in dementia due to Alzheimer's disease. Based on the interim analysis at week 2 sleep disturbance was reduced by about 71% (p=.012) and at week 6 about 78% (p=.02) for those on the active medication.

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test — Neutral
APDN Accesswire — March 26, 2025STONY BROOK, NY / ACCESS Newswire / March 26, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that Applied DNA Clinical Labs (ADCL), the Company's wholly-owned clinical laboratory subsidiary, has submitted a validation package to the New York State Department of Health (NYSDOH) to request approval as a laboratory-developed test (LDT) for a PCR-based assay for the detection and subtyping of influenza A (H5) virus, also known as H5 bird flu, highly pathogenic avian influenza, or H5N1 (collectively "H5 bird flu"). ADCL's Linea™ Avian Influenza H5 Dx assay …

ALT5 Sigma to Exhibit at Transact Las Vegas April 2-4, 2025 — Neutral
ALTS Accesswire — March 26, 2025LAS VEGAS, NV / ACCESS Newswire / March 26, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, announced its participation in the upcoming Transact Las Vegas. ALT5 will be exhibiting through the three days of the show at the Mandalay Bay, Las Vegas, providing product demonstrations, solutions and general information to many of the 3,000+ attendees starting April 2nd in booth #861.

Shareholders of TransMedics Group, Inc. Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX — Neutral
TMDX Accesswire — March 26, 2025NEW YORK, NY / ACCESS Newswire / March 26, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=138799&wire=1 or contact Joseph E. Levi, Esq.

Gryphon Digital Mining to Host Fourth Quarter and FY 2024 Earnings Conference Call — Neutral
GRYP Accesswire — March 26, 2025LAS VEGAS, NEVADA / ACCESS Newswire / March 26, 2025 / Gryphon Digital Mining, Inc. (Nasdaq:GRYP) ("Gryphon" or the "Company"), an innovative venture in the Bitcoin mining and AI space, announced today that management will host a conference call on March 31, 2024 at 4:30 PM Eastern Time to discuss results for its fourth quarter and full year ended December 31, 2024. Conference Call Information Date: March 31, 2024Time: 4:30 PM Eastern TimeToll Free: 888-506-0062International: 973-528-0011Participant Access Code: 626037Webcast: https://www.webcaster4.com/Webcast/Page/3030/52196 Conference Call Replay Information Toll Free: 877-481-4010International: 919-882-2331Replay Passcode: 52196Webcast replay: https://www.webcaster4.com/Webcast/Page/3030/52196 About Gryphon Digital Mining Gryphon Digital Mining, Inc. …

Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma — Neutral
XBIO Accesswire — March 26, 2025Investigator initiated study with collaboration partner, PeriNess, to be conducted at the Tel-Aviv Sourasky Medical Center FRAMINGHAM, MA / ACCESS Newswire / March 26, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers, today announced that its collaboration partner, PeriNess Ltd. ("PeriNess"), has entered into a Clinical Study Agreement (the "Agreement") to support an exploratory clinical study of Xenetic's systemic DNase I candidate, XBIO-015, in patients with relapsed/refractory osteosarcoma and Ewing sarcoma.

Sadot Group Expands into Asia - Launches South Korea Subsidiary — Neutral
SDOT Accesswire — March 26, 2025BURLESON, TX / ACCESS Newswire / March 26, 2025 / Sadot Group Inc. (Nasdaq:SDOT) ("Sadot Group", "Sadot" or the "Company"), an emerging player in the global Agri-food supply chain, is pleased to announce the establishment of Sadot Korea. Sadot Korea is Sadot's first Asian subsidiary in Seoul, South Korea, marking a strategic step in the company's global expansion strategy.
